These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 19123739)

  • 1. Carcinomas of the pancreas, gallbladder, extrahepatic bile ducts, and ampulla of vater share a field for carcinogenesis: a population-based study.
    Henson DE; Schwartz AM; Nsouli H; Albores-Saavedra J
    Arch Pathol Lab Med; 2009 Jan; 133(1):67-71. PubMed ID: 19123739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gall bladder cancer, extrahepatic bile duct cancer and ampullary carcinoma in New Zealand: Demographics, pathology and survival.
    Koea J; Phillips A; Lawes C; Rodgers M; Windsor J; McCall J
    ANZ J Surg; 2002 Dec; 72(12):857-61. PubMed ID: 12485219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas.
    Teh M; Wee A; Raju GC
    Cancer; 1994 Sep; 74(5):1542-5. PubMed ID: 7520348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver, gallbladder, extrahepatic bile ducts, and pancreas.
    Carriaga MT; Henson DE
    Cancer; 1995 Jan; 75(1 Suppl):171-90. PubMed ID: 8000995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of cancer of the pancreas, extrahepatic bile duct and ampulla of Vater in the United States, before and after the introduction of laparoscopic cholecystectomy.
    Urbach DR; Swanstrom LL; Khajanchee YS; Hansen PD
    Am J Surg; 2001 Jun; 181(6):526-8. PubMed ID: 11513778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Descriptive study of gallbladder, extrahepatic bile duct, and ampullary cancers in the United States, 1997-2002.
    Goodman MT; Yamamoto J
    Cancer Causes Control; 2007 May; 18(4):415-22. PubMed ID: 17264972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p53 protein immunoreactivity in cancers of the gallbladder, extrahepatic bile ducts and ampulla of Vater.
    Lee CS; Pirdas A
    Pathology; 1995 Apr; 27(2):117-20. PubMed ID: 7567135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. nm23-H1 protein immunoreactivity in cancers of the gallbladder, extrahepatic bile ducts and ampulla of Vater.
    Lee CS; Pirdas-Zivcic A
    Pathology; 1994 Oct; 26(4):448-52. PubMed ID: 7892048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biliary tract cancer incidence in the United States-Demographic and temporal variations by anatomic site.
    Castro FA; Koshiol J; Hsing AW; Devesa SS
    Int J Cancer; 2013 Oct; 133(7):1664-71. PubMed ID: 23504585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of staging laparoscopy in subsets of peripancreatic and biliary malignancies.
    Vollmer CM; Drebin JA; Middleton WD; Teefey SA; Linehan DC; Soper NJ; Eagon CJ; Strasberg SM
    Ann Surg; 2002 Jan; 235(1):1-7. PubMed ID: 11753036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rising incidence of biliary tract cancers in Shanghai, China.
    Hsing AW; Gao YT; Devesa SS; Jin F; Fraumeni JF
    Int J Cancer; 1998 Jan; 75(3):368-70. PubMed ID: 9455795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers.
    Nakazawa K; Dobashi Y; Suzuki S; Fujii H; Takeda Y; Ooi A
    J Pathol; 2005 Jul; 206(3):356-65. PubMed ID: 15892172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Gender-specific influencing factors on incidence, risk factors and outcome of carcinoma of the liver, gallbladder, extrahepatic bile duct and pancreas].
    Grundmann RT; Meyer F
    Zentralbl Chir; 2014 Apr; 139(2):184-92. PubMed ID: 24777600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gallbladder and extrahepatic bile duct cancers in the Americas: Incidence and mortality patterns and trends.
    Miranda-Filho A; Piñeros M; Ferreccio C; Adsay V; Soerjomataram I; Bray F; Koshiol J
    Int J Cancer; 2020 Aug; 147(4):978-989. PubMed ID: 31922259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epidemiology of rare types of hepatobiliary and pancreatic cancer from national cancer registry.
    Satake T; Morizane C; Rikitake R; Higashi T; Okusaka T; Kawai A
    J Gastroenterol; 2022 Nov; 57(11):890-901. PubMed ID: 36161533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma.
    Takada T; Amano H; Yasuda H; Nimura Y; Matsushiro T; Kato H; Nagakawa T; Nakayama T;
    Cancer; 2002 Oct; 95(8):1685-95. PubMed ID: 12365016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinoid tumors and small-cell carcinomas of the gallbladder and extrahepatic bile ducts: a comparative study based on 221 cases from the Surveillance, Epidemiology, and End Results Program.
    Albores-Saavedra J; Batich K; Hossain S; Henson DE; Schwartz AM
    Ann Diagn Pathol; 2009 Dec; 13(6):378-83. PubMed ID: 19917473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for extrahepatic bile duct cancers: Los Angeles County, California (USA).
    Chow WH; McLaughlin JK; Menck HR; Mack TM
    Cancer Causes Control; 1994 May; 5(3):267-72. PubMed ID: 8061176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smoking, Alcohol, and Biliary Tract Cancer Risk: A Pooling Project of 26 Prospective Studies.
    McGee EE; Jackson SS; Petrick JL; Van Dyke AL; Adami HO; Albanes D; Andreotti G; Beane-Freeman LE; Berrington de Gonzalez A; Buring JE; Chan AT; Chen Y; Fraser GE; Freedman ND; Gao YT; Gapstur SM; Gaziano JM; Giles GG; Grant EJ; Grodstein F; Hartge P; Jenab M; Kitahara CM; Knutsen SF; Koh WP; Larsson SC; Lee IM; Liao LM; Luo J; Milne RL; Monroe KR; Neuhouser ML; O'Brien KM; Peters U; Poynter JN; Purdue MP; Robien K; Sandler DP; Sawada N; Schairer C; Sesso HD; Simon TG; Sinha R; Stolzenberg-Solomon R; Tsugane S; Wang R; Weiderpass E; Weinstein SJ; White E; Wolk A; Yuan JM; Zeleniuch-Jacquotte A; Zhang X; Zhu B; McGlynn KA; Campbell PT; Koshiol J
    J Natl Cancer Inst; 2019 Dec; 111(12):1263-1278. PubMed ID: 31127946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.